1.中山大学孙逸仙纪念医院儿童医学中心,广东 广州 510289
2.中山大学孙逸仙纪念医院细胞分子诊断中心, 广东 广州 510289
侯乐乐,第一作者,研究方向:儿童内分泌及遗传代谢性疾病,E-mail:houlele@mail.sysu.edu.cn
纸质出版日期:2024-01-20,
收稿日期:2023-08-31,
录用日期:2023-11-27
扫 描 看 全 文
侯乐乐,林少汾,李晓娟等.48例原因不明矮身材儿童临床特征和致病基因分析[J].中山大学学报(医学科学版),2024,45(01):127-135.
HOU Lele,LIN Shaofen,LI Xiaojuan,et al.Clinical and Genetic Study on 48 Children with Short Stature of Unknown Etiology[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(01):127-135.
侯乐乐,林少汾,李晓娟等.48例原因不明矮身材儿童临床特征和致病基因分析[J].中山大学学报(医学科学版),2024,45(01):127-135. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.006.
HOU Lele,LIN Shaofen,LI Xiaojuan,et al.Clinical and Genetic Study on 48 Children with Short Stature of Unknown Etiology[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(01):127-135. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.006.
目的
2
总结原因不明矮身材儿童的临床特征并探讨其致病基因,为临床精准诊疗提供依据。
方法
2
收集我院儿科内分泌专科2018年1月至2022年8月就诊的未能明确诊断的矮身材儿童临床表现、实验室检查及全外显子组测序(WES)结果进行回顾性分析,根据不同作用机制对致病基因进行归纳总结。
结果
2
纳入患儿48例(男性30例,女性18例),年龄(7.73±3.97)岁,身高标准差分值为-3.63±1.67;临床表现:特殊面容33例(68.8%),体型或骨骼系统异常31例(64.6%),围产期异常26例(54.2%,其中61.5%为小于胎龄儿),内分泌系统异常24例(50.0%,其中87.5%生长激素(GH)峰值低于正常),矮身材家族史21例(43.8%);实验室检查:GH激发试验峰值(9.72±7.25)ng/mL,IGF-1 标准差分值为-0.82±1.42,骨龄与年龄差值(-0.93±1.39)岁;WES共发现相关基因变异者25例,其中14例(56.0%)为致病变异,6例(24.0%)为可能致病变异,5例(20.0%)为意义未明变异;评价为致病及可能致病变异的基因共14个,其中影响细胞内信号通路10个(
PTPN11、RAF1、RIT1、ARID1B、ANKRD11、CSNK2A1、SRCAP、CUL7、SMAD4
和
FAM111A
),影响细胞外基质(ECM)4个(
ACAN、FBN1、COL10A1
和
COMP
)。
结论
2
临床上表现为严重矮身材伴特殊面容、非匀称体型、骨骼系统异常、小于胎龄儿、GH峰值低于正常和矮身材家族史等特征的儿童,其病因需考虑罕见单基因疾病的可能,WES是提高单基因性矮小症诊断效能的重要手段。本组患儿致病基因中,主要致病机制是影响细胞内信号通路和ECM组分或功能,进一步研究有助于发现和研究新的矮小症致病变异和基因功能。
Objective
2
To explore the clinical features and causative genes of short stature children with unknown etiology, providing evidence for precise clinical diagnosis and treatment.
Methods
2
The study recruited children with suspected but undiagnosed short stature from the pediatric endocrinology department in our hospital between January 2018 and August 2022. A retrospective analysis was performed on the clinical manifestations, laboratory test and whole exome sequencing (WES) results. Causative genes were classified and analyzed according to different pathogenic mechanisms.
Results
2
A total of 48 children (30 boys and 18 girls) were enrolled, aged 7.73 ± 3.97 years, with a height standard deviation score ( HtSDS) of -3.63 ± 1.67. Of the patients, 33 (68.8%) suffered from facial anomalies, 31 (64.6%) from skeletal abnormalities, 26 [54.2%, 61.5% of whom born small for gestational age (SGA)] from perinatal abnormalities, 24 [50.0%, 87.5% of whom with growth hormone (GH) peak concentration below normal] from endocrine disorders and 21(43.8%) had a family history of short stature. Laboratory tests showed that GH peak concentration following stimulation test was (9.72 ± 7.25) ng/mL, IGF-1 standard deviation score was -0.82 ± 1.42, the difference between bone age and chronological age was -0.93 ± 1.39 years. Of the 25 cases with mutant genes found by WES, 14 (56.0%) had pathogenic mutation, 6 (24.0%) likely pathogenic mutation, and 5 (20.0%) mutation of uncertain significance. Pathogenic and likely pathogenic variants were identified in 14 genes, including 10 affecting intracellular signaling pathways (
PTPN11
,
RAF1
,
RIT1
,
ARID1B
,
ANKRD11
,
CSNK2A1
,
SRCAP
,
CUL7
,
SMAD4
and
FAM111A
) and 4 affecting extracellular matrix (ECM) components or functions (
ACAN
,
FBN1
,
COL10A1
and
COMP)
.
Conclusions
2
A rare monogenic disease should be considered as the possible etiology for children with severe short stature accompanied by facial anomalies, disproportionate body types, skeletal abnormalities, SGA, GH peak concentration below normal and a family history of short stature. WES played an important role in identifying the monogenic causes of short stature. This study indicated that affecting growth plate cartilage formation through intracellular signaling pathways and ECM components or functions was the main mechanism of causative genes leading to severe short stature in children. Further research may help discover and study new pathogenic variants and gene functions.
矮身材儿童临床特征全外显子组测序基因变异致病基因
short staturechildrenclinical featurewhole exome sequencing (WES)gene mutationcausative gene
Li Q, Chen Z, Wang J, et al. Molecular diagnostic yield of exome sequencing and chromosomal microarray in short stature: a systematic review and meta-analysis[J]. JAMA Pediatr, 2023: e233566.
Patel R, Bajpai A. Evaluation of short stature in children and adolescents[J]. Indian J Pediatr, 2021, 88(12):1196-1202.
Polidori N, Castorani V, Mohn A, et al. Deciphering short stature in children[J]. Ann Pediatr Endocrinol Metab, 2020, 25(2):69-79.
Zhou E, Hauser BR, Jee YH. Genetic evaluation in children with short stature[J]. Curr Opin Pediatr, 2021, 33(4):458-463.
Kamil G, Yoon JY, Yoo S, et al. Clinical relevance of targeted exome sequencing in patients with rare syndromic short stature[J]. Orphanet J Rare Dis, 2021, 16(1):297.
Kärkinen J, Miettinen PJ, Raivio T, alet. Etiology of severe short stature below -3 SDS in a screened Finnish population[J]. Eur J Endocrinol, 2020, 183(5):481-488.
吴瑞,石宇,黄道超,等.基于二代测序技术的矮小症患者表型与基因型研究[J].重庆医科大学学报,2022,47(3):319-324.
Wu R, Shi Y, Huang DC, et al.Study on phenotype and genotype of short stature based on second-generation sequencing technology[J]. J Chongqing Med Univ,2022,47(3):319-324.
中华医学会儿科学分会内分泌遗传代谢学组. 矮身材儿童诊治指南[J]. 中华儿科杂志, 2008, 46(6): 428-430.
Chinese Society of Pediatric Endocrinology and Metabolism. Guidelines for the diagnosis and treatment of children with short stature[J]. Chin J Pediatr, 2008, 46(6): 428-430.
李辉, 季成叶, 宗心南, 等. 中国0~18岁儿童、青少年身高、体重的标准化生长曲线[J]. 中华儿科杂志, 2009, 47(7): 487-492.
Li H, Ji CY, Zong XN, et al. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years[J]. Chin J Pediatr, 2009, 47(7): 487-492.
李燕虹, 杜敏联, 马华梅, 等. 吡啶斯的明与左旋多巴联合激发试验对儿童生长激素缺乏症的诊断价值[J]. 中华内分泌代谢杂志, 2004, 20(3): 227-230.
Li YH, Du ML, Ma HM, et al. Diagnostic value of provocative test by pyridostigmine combined with levodopa for growth hormone deficiency in children[J]. Chin J Endocrinol Metab, 2004, 20(3): 227-230.
许珊珊, 顾学范, 潘慧, 等. 儿童青少年血清胰岛素生长因子-1及胰岛素因子结合蛋白-3的正常参考值研究[J]. 临床儿科杂志, 2009, 27(12): 1105-1110.
Xu SS, Gu XF, Pan H, et al. Reference values for serum IGF-1 and IGFBP-3 in children and adolescents[J]. J Clin Pediatr, 2009, 27(12): 1105-1110.
张绍岩, 刘丽娟, 吴真列, 等. 中国人手腕骨发育标准-中华05 I.TW3-C RUS、TW3-C腕骨和RUS-CHN方法[J]. 中国运动医学杂志, 2006, 25(5): 509-516.
Zhang SY, Liu LJ, Wu ZL, et al. The skeletal development standards of hand and wrist for Chinese children-China 05 I. TW3 - C RUS, TW3 - C Carpal, and RUS- CHN methods[J]. Chin J Sports Med, 2006, 25(5): 509-516.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-424.
Jee YH, Andrade AC, Baron J, et al. Genetics of short stature[J]. Endocrinol Metab Clin North Am, 2017, 46(2):259-281.
van der Steen M, Pfundt R, Maas S, et al. ACAN gene mutations in short children born SGA and response to growth hormone treatment[J]. J Clin Endocrinol Metab, 2017, 102(5):1458-1467.
Tüysüz B, Kasap B, Uludağ Alkaya D, et al. Investigation of (Epi)genetic causes in syndromic short children born small for gestational age[J]. Eur J Med Genet, 2023, 66(11):104854.
杨露露, 王伟, 施锦绣, 等. 原因不明矮小症致病基因研究(附77例报告)[J]. 中国实用儿科杂志, 2017, 32(12): 942-946.
Yang LL, Wang W, Shi JX, et al. Genetic studies of 77 cases of short stature with unknown etiology[J]. Chin J Pract Pediatr, 2017, 32(12): 942-946.
Huang Z, Sun Y, Fan Y, et al. Genetic evaluation of 114 Chinese short stature children in the next generation era: a single center study[J]. Cell Physiol Biochem, 2018, 49(1):295-305.
Fan X, Zhao S, Yu C, et al. Exome sequencing reveals genetic architecture in patients with isolated or syndromic short stature[J]. J Genet Genomics, 2021, 48(5):396-402.
Li X, Yao R, Chang G, et al. Clinical profiles and genetic spectra of 814 Chinese children with short stature[J]. J Clin Endocrinol Metab, 2022, 107(4):972-985.
0
浏览量
15
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构